BioLife Solutions BLFS Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's additional paid-in capital?
- BioLife Solutions (BLFS) reported additional paid-in capital of $710.81M in Q1 2026.
- How has BioLife Solutions's additional paid-in capital changed year-over-year?
- BioLife Solutions's additional paid-in capital increased by 3.3% year-over-year, from $688.09M to $710.81M.
- What is the long-term trend for BioLife Solutions's additional paid-in capital?
- Over 5 years (2020 to 2025), BioLife Solutions's additional paid-in capital has grown at a 18.6% compound annual growth rate (CAGR), from $302.6M to $711.4M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.